US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Related articles
French sports minister calls for sanctions after Monaco player tapes over anti
PARIS (AP) — France’s sports minister has called for soccer club Monaco to be sanctioned after one o2024-05-21Revealed: England's smart motorways lost power nearly 400 times in two years
The technology behind England's smart motorways network stopped working on a regular basis leaving d2024-05-21Hybrid rice market expands in Asia
The increased yields of a hybrid rice strain developed in China have helped countries participating2024-05-21Foreign businessmen seek new opportunities at Canton Fair
GUANGZHOU, April 21 (Xinhua) -- In 1954, Jack Perry, founder of the London Export Corporation, led a2024-05-21Nadal returns to Roland Garros to practice amid doubts over fitness and form
PARIS (AP) — Rafael Nadal returned to Roland Garros on Monday to practice and try and figure out whe2024-05-21Cruz breaks slump with 3 hits, Jones cruises as Pirates beat Brewers 4
PITTSBURGH (AP) — Oneil Cruz broke out of a slump with three hits, rookie Jared Jones allowed one ru2024-05-21
atest comment